Market Overview:
The global lung biopsy systems market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of lung cancer, technological advancements in biopsy systems, and rising demand for minimally invasive procedures. Based on type, the global lung biopsy systems market is segmented into needle biopsy, thoracoscopic biopsy, and transbronchial biopsy. The needle biopsy segment is expected to account for the largest share of the global market in 2018. This can be attributed to its low cost and easy availability compared with other types ofbiopsiesystems.
Product Definition:
Lung biopsy systems are devices that allow for the collection of tissue samples from the lungs. These systems can include a number of different tools, such as needles, forceps, and scissors, that are used to remove small pieces of tissue from the lungs. Lung biopsy systems can be used to diagnose a variety of lung conditions, including cancer and tuberculosis. They can also be used to determine the extent or severity of a lung disease.
Needle Biopsy:
Needle biopsy is a minimally invasive diagnostic procedure used to obtain tissue for microscopic analysis. Needle biopsy can be performed through the skin, muscle, or vein. It is an alternative to surgical lung biopsy and less invasive than incisional lung biopsies which makes it more popular among patients with a fear of needles or surgical procedures.
Thoracoscopic Biopsy:
Thoracoscopic biopsy is a minimally invasive diagnostic procedure used to obtain tissue samples from the lung. It's major applications include detection of lung cancer, assessment of pulmonary lesions and diagnosis of pneumonia & tuberculosis. Thoracoscopic biopsy systems market includes products such as thoracoscope, needle driver, suction canister and other accessories which are used in performing this procedure.
Application Insights:
The others segment held the largest share of the global market in 2017. This is attributed to growing demand for lung biopsies from various research studies and a few clinical applications, such as diagnosis of tuberculosis or asbestos-related diseases. In addition, lung biopsy is used for detecting cancerous cells in non-small cell lung carcinoma (NSCLC) patients due to its high yield and specificity.
However, hospitals are expected to be the fastest growing application segment over the forecast period owing to rising prevalence of chronic diseases like cardiovascular disorders, diabetes mellitus type 2 and cancer across regions. For instance, according to WHO statistics published in 2018 regarding cancer incidence worldwide; it was estimated that around 1 person dies from NSCLD every 6 seconds globally while about 14 deaths occur due these conditions per minute globally. Thus increasing number of patients suffering from chronic diseases will boost product demand at a significant rate during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of technologically advanced products, and favorable reimbursement policies & regulatory approvals by government agencies. The U.S.-based companies are engaged in extensive research activities to develop novel biopsy devices that meet the high demand for lung cancer detection across this region.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as increasing prevalence of lung cancer and other respiratory diseases coupled with growing awareness about early diagnosis among patients in this region will drive regional growth during the forecast period from 2018-2030 (USD Million). Moreover, an increase in number of international collaborations between Asian countries and North America is anticipated to boost revenue generation from biopsy systems market over next seven years (USD Million).
Growth Factors:
- Increasing incidence of lung cancer: The incidence of lung cancer is increasing at an alarming rate across the globe. This is primarily due to the changing lifestyle and environmental factors. As a result, there is an increased demand for diagnostic and treatment modalities for lung cancer, which in turn is propelling the growth of the Lung Biopsy Systems market.
- Technological advancements: The development of novel technologies such as image-guided biopsy systems has revolutionized the field of diagnostics and helped in early diagnosis and treatment of various diseases including lung cancer. This is driving the growth of Lung Biopsy Systems market globally.
- Rising awareness about early diagnosis: There is a growing awareness among people about the importance of early diagnosis in order to improve prognosis and increase chances for cure or remission from various diseases including lung cancer. This is boosting demand for diagnostic procedures such as biopsies, thereby propelling growth prospects for Lung Biopsy Systems market globally .
Scope Of The Report
Report Attributes
Report Details
Report Title
Lung Biopsy Systems Market Research Report
By Type
Needle Biopsy, Thoracoscopic Biopsy, Transbronchial Biopsy
By Application
Hospitals, Cancer Research Centers, Specialty Clinics, Others
By Companies
BD, Medtronic, Olympus, Roche, QIAGEN
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
184
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global Lung Biopsy Systems Market Report Segments:
The global Lung Biopsy Systems market is segmented on the basis of:
Types
Needle Biopsy, Thoracoscopic Biopsy, Transbronchial Biopsy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Cancer Research Centers, Specialty Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD
- Medtronic
- Olympus
- Roche
- QIAGEN
Highlights of The Lung Biopsy Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Needle Biopsy
- Thoracoscopic Biopsy
- Transbronchial Biopsy
- By Application:
- Hospitals
- Cancer Research Centers
- Specialty Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lung Biopsy Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lung biopsy systems are medical devices used to remove tissue from the lungs for examination.
Some of the major players in the lung biopsy systems market are BD, Medtronic, Olympus, Roche, QIAGEN.
The lung biopsy systems market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lung Biopsy Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Lung Biopsy Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Lung Biopsy Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Lung Biopsy Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Lung Biopsy Systems Market Size & Forecast, 2018-2028
4.5.1 Lung Biopsy Systems Market Size and Y-o-Y Growth
4.5.2 Lung Biopsy Systems Market Absolute $ Opportunity
Chapter 5 Global Lung Biopsy Systems Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Lung Biopsy Systems Market Size Forecast by Type
5.2.1 Needle Biopsy
5.2.2 Thoracoscopic Biopsy
5.2.3 Transbronchial Biopsy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Lung Biopsy Systems Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Lung Biopsy Systems Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Cancer Research Centers
6.2.3 Specialty Clinics
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lung Biopsy Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lung Biopsy Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Lung Biopsy Systems Analysis and Forecast
9.1 Introduction
9.2 North America Lung Biopsy Systems Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Lung Biopsy Systems Market Size Forecast by Type
9.6.1 Needle Biopsy
9.6.2 Thoracoscopic Biopsy
9.6.3 Transbronchial Biopsy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Lung Biopsy Systems Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Cancer Research Centers
9.10.3 Specialty Clinics
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Lung Biopsy Systems Analysis and Forecast
10.1 Introduction
10.2 Europe Lung Biopsy Systems Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Lung Biopsy Systems Market Size Forecast by Type
10.6.1 Needle Biopsy
10.6.2 Thoracoscopic Biopsy
10.6.3 Transbronchial Biopsy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Lung Biopsy Systems Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Cancer Research Centers
10.10.3 Specialty Clinics
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Lung Biopsy Systems Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Lung Biopsy Systems Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Lung Biopsy Systems Market Size Forecast by Type
11.6.1 Needle Biopsy
11.6.2 Thoracoscopic Biopsy
11.6.3 Transbronchial Biopsy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Lung Biopsy Systems Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Cancer Research Centers
11.10.3 Specialty Clinics
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Lung Biopsy Systems Analysis and Forecast
12.1 Introduction
12.2 Latin America Lung Biopsy Systems Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Lung Biopsy Systems Market Size Forecast by Type
12.6.1 Needle Biopsy
12.6.2 Thoracoscopic Biopsy
12.6.3 Transbronchial Biopsy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Lung Biopsy Systems Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Cancer Research Centers
12.10.3 Specialty Clinics
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Lung Biopsy Systems Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Lung Biopsy Systems Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Lung Biopsy Systems Market Size Forecast by Type
13.6.1 Needle Biopsy
13.6.2 Thoracoscopic Biopsy
13.6.3 Transbronchial Biopsy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Lung Biopsy Systems Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Cancer Research Centers
13.10.3 Specialty Clinics
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lung Biopsy Systems Market: Competitive Dashboard
14.2 Global Lung Biopsy Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BD
14.3.2 Medtronic
14.3.3 Olympus
14.3.4 Roche
14.3.5 QIAGEN
